Intrauterine growth restriction (IUGR) refers to a fetus with an estimated weight less than 10th percentile for gestational age. IUGR can occur due to reduced fetal growth potential from genetic/structural issues or infections, or reduced fetal growth support from maternal/placental factors like malnutrition, hypoxia, or drugs. IUGR increases risks of complications during labor like meconium aspiration or fetal distress. Intrauterine death refers to fetal death after 20 weeks of gestation, which can have unknown causes or be due to maternal/fetal/placental conditions like preeclampsia, infections, or cord accidents. Diagnosis involves assessing fetal movement and heart rate. Management depends on gestational
6. Risk factors of IUGR
Multiple gestations
History of IUGR in previous pregnancies
Current heavy smokers
Current drug users
Pregnancies where SFH is less than expected
Women with underlying disorders (HTN ,Diabetes,
cyanotic heart disease, Antiphospholipid
syndrome)
7.
8. Classification of IUGR
Symmetrical
Symmetrically small fetuses are normally associated
with factors that directly impair growth e.g
chromosomal abnormalities and infections
Asymmetrical
It is associated with uteroplacental insufficiency
which leads to reduced oxygenation to fetus and
impaired excretion of carbon dioxide leads to
hypoxia and growth asymmetry
9. Fetal brain ,myocardium and adrenals are adequately
perfused so they are spared of impaired growth while
kidneys, skin, liver, limbs do not grow proportionally.
The result of these circulatory changes is an
asymmetrical fetus with brain sparing ,decrease
abdominal girth and skin thickness
The vasoconstriction in the fetal kidneys results in
impaired urine formation and oligohydrominias
Chronic fetal hypoxia leads to fetal acedemia both
metabolic and respiratory which leads to IUD
IUGR fetuses are at increased risk of asphyxia during
labour due to uterine contraction which further
compromise uteroplacental circulation
10. Antenatal fetal blood sampling shows
Decrease glucose ,amino acids, thyroxine and
insulin levels
Increased levels of corticosteroids and
catecholamines due to asymmetrically increased
perfusion of adrenals
Increased erythropoetin and reticulocyes (hypoxia)
11. Management
Detection of IUGR contains two elements
1. Accurate assessment of gestational age
o Crown rump length before 13wks + 6 days
o Head circumference between 13wks-20wks
2. Recognition of fetal smallness
o Ultrasound biometry (biparietal diameter, head
circumference, abdominal circumference and femur
length) serially at interval of 4wks but now it is
performed in high risk pregnancies
12. USG shows whether the fetus is symmetrical or
asymmetrical
If symmetrical IUGR with normal volume of
amniotic fluid then amniocentesis and fetal
karyotype should be offered
Asymmetrical IUGR has relatively decreased
abdominal circumference and oligohydrominias
13. At present there is no widely accepted treatment is present for
IUGR related to uteroplacental insufficiency
Smoking alcohol and drug abuse should be stopped
Nutritional supplementation of mother
Aspirin in low dose may have a role in high risk pregnancies of
IUGR but it is not established
When growth restriction is severe and fetus is too immature to
deliver bed rest in hospital is advised in effort to maximize
blood flow to placenta however evidence supporting this is
limited
If fetures of acidosis and poor biophysical profile is present then
C-section should be performed otherwise wait for gestational
maturity and deliver by normal vaginal delivery
Nutritional supplementation of mother
Maintainance of good glycemic control and maintain
hypertension
and other morbidities
14. Complications
Perinatal mortality and morbidity of IUGR is 3-20%
more than normal infants
Antepartum period
Still births
Oligohydrominias
During labour
High incidence of meconium aspiration
Fetal distress
Intrapartum fetal death
15. o Other IU complications include polycythemia ,
metabolic disorders
o Long term complications include
Hypertension
Diabetes
17. Definition
In utero death of a fetus after 20 weeks’ gestation
and birth.
Antenatal demise occurs before labour
Intrapartal demise occurs after the onset of labour
18. Etiology
Unknown in 25 – 60% of cases
Identifiable causes can be attributed to
Maternal conditions
Fetal conditions
Placental conditions
21. Maternal causes
Antiphospholipid syndrome
Diabetes
Hypertension
Sle
Trauma
Abnormal labour
Post term pregnancy
thrombophilia
Sepsis
Cyanotic heart disease
Epilepsy
Severe anemia
22. Diagnosis to confirm IUD
History and examination
Absence of fetal movements
-Gradual retrogression of the height of the uterus
- Uterine tone is diminished
- Fetal movement are not felt during palpation.
- Fetal heart sound are not audible
23. Radiography X-ray abdomen
Spalding sign:it usually appears after 7 days of
IUD.it shows
-overlapping of cranial bones
USG shows
-Absent fetal movements and fetal heart activity
-oligohydrominias
24.
25. Management
DIC is the most serious consequence with prolong
fetal demise >2 wks resulting from release of
tissue thromboplastin from deteriorating fetal
organs
DIC should be ruled out with appropriate labortary
testing.
Platelet count, d-dimer, fibrinogen ,PT. If DIC is
identified immediate delivery is necessary
If no DIC then mode of delivery may be as follows
26. Dilatation and evacuation procedure may be
appropriate in pregnancies of <20 weeks’ gestation
Induction of labour with oxytocin is appropriate in
pregnancies of >20 weeks
Cessarean delivery is almost never appropriate for
dead fetus
Counsel the patient about the loss
27. Identify cause of death by
Cervical/placental culture for susoected infection
Karyotype for aneuploidy
Maternal blood for Kleihauer-betke (peripheral
smear for suspected fetometernal bleed )